New SEC Form D filing

GOA Therapeutics Corp, 2026-11-05

A new SEC Form D private-offering notice from West Palm Beach, FL, a $225,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

GOA Therapeutics Corp site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing GOA26, a first-in-class intravenous drug candidate for acute alcohol intoxication and poisoning.

Filed 2026-11-05Filed to raise $225,000,000First money in 2026-10-22Raised so far $300,000HQ (as filed) West Palm Beach, FLSector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified goathera.com↗Named in the filing 4 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source